1. This stock is listed on OTC, so it doesn't matter if progress is made or not: shorts ALWAYS win, I reiterate ALWAYS.
2.. What is progress? Lympro is still 9-14 months away from possible approval (H2 2014 is between July and 31 December)
3. Parkinson disease trials need primate studies first. THEY DO NOT EVEN HAVE A TRIAL DESIGN FOR THESE STUDIES PROPOSED TO THE FDA.
4.. Parkinson Disaese: they need to do a feasibility stud first to see if the brain accepts a device (or give non-bearable side effects) that is able to release MANF. That will take a year at least.
5.. Orphan drug designation for ophtamology... Still no trial design for preclinical and clinical studies.
And some of you think this will go to $.20/share soon. Let's be realistic: this will go south $.02 and probably lower!
Sentiment: Strong Sell
Here is the bottom line. I weigh your 5 sentences to everything I’ve read on Amarantus clear winner is…(I’ll give you one guess)
You have to do better than this.
Have a nice day.
Sentiment: Strong Buy
I concur. Its typical bashers Playbook. Confound the board with jibberish and hope people get scared. I am not scared. I am also holding for the long term as the upside is immense
Last 4 points are correct. But the poster is missing the mantra. We are not here to see AMBS bring medicines to the market. We are here to "trade off" the speculations and market sentiment that drives the pps up/down. If I can make 500% near term, I could care less when AMBS brings MANF PD drug, 1 year or 20 years from now.
Nearly 95% of investors over time, confuse why they bought a stock in the first place. We buy stocks to make profits, not to see a company grow/fail/succeed.
TWTR surged 91% when it has zero revenues, a pps target of under 30$, and sell rating.
So whats your stake in all of this? What do you stand to gain by bashing a penny stock at 4 cents? You obviously concede that it is a penny stock. it is at 4c because they still have a lot of work to do, we all know that. why are you so angry?